HK1130175A1 - Tansdermally absorbable preparation comprising anti-dementia agent - Google Patents
Tansdermally absorbable preparation comprising anti-dementia agentInfo
- Publication number
- HK1130175A1 HK1130175A1 HK09108096.7A HK09108096A HK1130175A1 HK 1130175 A1 HK1130175 A1 HK 1130175A1 HK 09108096 A HK09108096 A HK 09108096A HK 1130175 A1 HK1130175 A1 HK 1130175A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tansdermally
- absorbable preparation
- dementia agent
- dementia
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79829606P | 2006-05-08 | 2006-05-08 | |
PCT/JP2006/325813 WO2007129427A1 (ja) | 2006-05-08 | 2006-12-25 | 抗認知症薬物の経皮吸収製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1130175A1 true HK1130175A1 (en) | 2009-12-24 |
Family
ID=38667540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09108096.7A HK1130175A1 (en) | 2006-05-08 | 2009-09-04 | Tansdermally absorbable preparation comprising anti-dementia agent |
Country Status (17)
Country | Link |
---|---|
US (2) | US7858114B2 (xx) |
EP (1) | EP2016939B1 (xx) |
JP (1) | JP5122445B2 (xx) |
KR (1) | KR20090009951A (xx) |
CN (1) | CN101460156B (xx) |
AU (1) | AU2006343077B2 (xx) |
BR (1) | BRPI0621655A2 (xx) |
CA (1) | CA2651596C (xx) |
ES (1) | ES2466647T3 (xx) |
HK (1) | HK1130175A1 (xx) |
IL (1) | IL195174A0 (xx) |
IN (1) | IN266817B (xx) |
MY (1) | MY149152A (xx) |
NO (1) | NO20084614L (xx) |
NZ (1) | NZ572809A (xx) |
RU (1) | RU2428179C2 (xx) |
WO (1) | WO2007129427A1 (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2670991A1 (en) * | 2006-12-01 | 2008-06-05 | Nitto Denko Corporation | Percutaneously absorbable preparation comprising donepezil |
US20100048628A1 (en) * | 2006-12-01 | 2010-02-25 | Sumiyo Nishi | Method for suppressing discoloration over time of adhesive preparation containing donepezil |
CA2719605C (en) * | 2008-03-25 | 2016-07-12 | Teikoku Seiyaku Co., Ltd. | Transdermally absorbable preparation |
US20090291127A1 (en) * | 2008-05-21 | 2009-11-26 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
RU2481826C2 (ru) * | 2008-05-30 | 2013-05-20 | Нитто Денко Корпорейшн | Содержащий донепезил адгезивный препарат и упаковка для него |
CA2725484A1 (en) * | 2008-05-30 | 2009-12-03 | Eisai R&D Management Co., Ltd. | Percutaneously absorbable preparation |
US20100080842A1 (en) * | 2008-09-30 | 2010-04-01 | Jianye Wen | Transdermal extended-delivery donepezil compositions and methods for using the same |
US20100278895A1 (en) | 2009-04-30 | 2010-11-04 | Medtronic, Inc. | Antioxidants and antimicrobial accessories including antioxidants |
WO2011034323A2 (en) * | 2009-09-16 | 2011-03-24 | Samyang Corporation | Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system |
JP5795264B2 (ja) | 2009-12-16 | 2015-10-14 | 後藤 武 | 抗認知症薬物の経皮吸収製剤 |
CN102834092A (zh) * | 2009-12-16 | 2012-12-19 | 后藤武 | 抗痴呆药物的经皮吸收制剂 |
JP2012236773A (ja) * | 2009-12-16 | 2012-12-06 | Goto Takeshi | 抗認知症薬物の経皮吸収製剤 |
CN102711744B (zh) * | 2009-12-22 | 2014-06-25 | 阿西诺股份公司 | 用于施用利凡斯的明和其衍生物的透皮治疗系统 |
US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
NZ605352A (en) * | 2010-06-30 | 2013-10-25 | Nal Pharmaceuticals Ltd | Process for producing glycosaminoglycans |
DK2468274T3 (en) | 2010-12-14 | 2015-08-31 | Acino Ag | Transdermal therapeutic system for administration of an active substance |
US8911427B2 (en) * | 2010-12-28 | 2014-12-16 | Medtronic, Inc. | Therapeutic agent reservoir delivery system |
TWI433904B (zh) * | 2011-01-12 | 2014-04-11 | Taiwan Biotech Co Ltd | 多奈哌齊經皮貼片 |
KR101054317B1 (ko) | 2011-01-28 | 2011-08-08 | 신신제약 주식회사 | 리바스티그민을 함유하는 경피흡수제제 |
KR101317158B1 (ko) * | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
WO2012161489A2 (ko) * | 2011-05-20 | 2012-11-29 | 에스케이케미칼 주식회사 | 리바스티그민 함유 패취 |
KR101395557B1 (ko) * | 2011-08-25 | 2014-05-16 | 아이큐어 주식회사 | 경피 흡수 제제 및 그 제조방법 |
KR101239150B1 (ko) * | 2012-02-28 | 2013-03-06 | 에스케이케미칼주식회사 | 도네페질-함유 경피흡수제제 및 그의 제조방법 |
KR101964295B1 (ko) * | 2012-09-05 | 2019-04-01 | 주식회사 한독 | 피부 자극이 감소된 메만틴 경피전달 시스템 |
CN104853755B (zh) * | 2012-12-13 | 2017-08-22 | H.隆德贝克有限公司 | 包含沃替西汀和多奈哌齐的组合物 |
JP6151935B2 (ja) * | 2013-03-11 | 2017-06-21 | 日東電工株式会社 | 経皮吸収促進用組成物および貼付製剤 |
ES2829807T3 (es) | 2014-02-20 | 2021-06-02 | Nal Pharmaceutical Group Ltd | Sistema de administración transdérmica de fármacos que contiene donepezilo |
CN108135860A (zh) | 2015-06-22 | 2018-06-08 | 考里安国际公司 | 包含难溶性治疗剂的透皮粘合剂组合物 |
JP6148416B2 (ja) | 2015-06-29 | 2017-06-14 | 積水化学工業株式会社 | コアシェル構造体及び外用剤 |
JP7174632B2 (ja) | 2016-06-23 | 2022-11-17 | コリウム, インコーポレイテッド | 親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス |
EP3490541A2 (en) * | 2016-07-27 | 2019-06-05 | Corium International, Inc. | Transdermal formulation and delivery method of low solubility or unstable unionized neutral drugs byin situ |
MX2019001104A (es) * | 2016-07-27 | 2019-10-02 | Corium Int Inc | Sistemas de suministro transdermico de memantina. |
US20180028461A1 (en) * | 2016-07-27 | 2018-02-01 | Corium International, Inc. | Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery |
US20200009174A1 (en) * | 2017-02-28 | 2020-01-09 | Kimberly-Clark Worldwide, Inc. | Synergistic composition for maintenance of healthy balance of microflora |
CN108096690B (zh) * | 2017-04-07 | 2019-08-20 | 杭州多泰科技有限公司 | 一种诱导循环肿瘤细胞转移的可移植支架的制备方法 |
KR102033686B1 (ko) | 2017-05-19 | 2019-10-18 | 보령제약 주식회사 | 도네페질을 함유하는 마이크로니들 경피 패치 |
JP2020529229A (ja) * | 2017-07-26 | 2020-10-08 | コリウム, インコーポレイテッド | 溶媒充填細孔を有する微多孔膜を有する経皮送達システム |
AU2018383672A1 (en) | 2017-12-13 | 2020-07-02 | Corium, LLC. | Method for depot creation during transdermal drug delivery |
WO2019126531A1 (en) | 2017-12-20 | 2019-06-27 | Corium, Inc. | Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point |
CN108926549A (zh) * | 2018-09-27 | 2018-12-04 | 安徽安科余良卿药业有限公司 | 卡巴拉汀凝胶贴膏及其制备方法 |
KR102489860B1 (ko) * | 2021-09-02 | 2023-01-19 | 동아에스티 주식회사 | 메만틴 에난트산염을 포함하는 치매 치료용 경피흡수 제제 |
CN115957200A (zh) * | 2023-02-23 | 2023-04-14 | 广州新济药业科技有限公司 | 一种美金刚透皮贴剂及制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0491853A4 (en) | 1989-09-14 | 1992-11-04 | Cygnus Therapeutic Systems | Transdermal delivery device having delayed onset |
JP2977254B2 (ja) | 1990-09-04 | 1999-11-15 | 積水化学工業株式会社 | 経皮吸収貼付剤 |
US5273756A (en) | 1991-08-23 | 1993-12-28 | Cygnus Therapeutic Systems | Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset |
JPH06199659A (ja) * | 1992-10-28 | 1994-07-19 | Hisamitsu Pharmaceut Co Inc | 経皮治療用装置 |
WO1995001167A2 (en) * | 1993-06-25 | 1995-01-12 | Alza Corporation | Incorporating poly-n-vinyl amide in a transdermal system |
US5635203A (en) | 1994-09-29 | 1997-06-03 | Alza Corporation | Transdermal device having decreased delamination |
DE19533772C1 (de) * | 1995-09-12 | 1998-01-02 | Hexal Ag | Tacrin/Selegilin-Pflaster |
DE19653605C2 (de) * | 1996-12-20 | 2002-11-28 | Roehm Gmbh | Haft- und Bindemittel für dermale oder transdermale Therapiesysteme und dessen Verwendung zur Herstellung eines transdermalen Therapiesystems |
JPH10315016A (ja) | 1997-05-15 | 1998-12-02 | Nissan Diesel Motor Co Ltd | チャック装置 |
JP3987655B2 (ja) * | 1998-03-03 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬を含有した経皮適用製剤又は坐剤 |
GB9917290D0 (en) | 1999-07-22 | 1999-09-22 | Glaxo Wellcome Spa | Pharmaceutical composition |
DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
FR2814368B1 (fr) * | 2000-09-26 | 2004-05-07 | Pf Medicament | Preparation pharmaceutique a base d'oxans |
US20040028724A1 (en) * | 2000-11-07 | 2004-02-12 | Takaaki Terahara | Pharmaceutical preparation of percutaneous absorption type |
DE10060550C1 (de) | 2000-12-06 | 2002-04-18 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit dem Wirkstoff Oxybutynin und Verfahren zur Herstellung Oxybutynin enthaltender Wirkstoffschichten |
EP1437130A4 (en) * | 2001-10-17 | 2009-08-26 | Hisamitsu Pharmaceutical Co | PERCUTANEOUS ABSORPTION PREPARATIONS |
DE10220230A1 (de) * | 2002-05-06 | 2003-11-27 | Sanol Arznei Schwarz Gmbh | Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms |
JP4274951B2 (ja) * | 2004-01-07 | 2009-06-10 | 久光製薬株式会社 | 異型断面繊維を使用した支持体を有するテーピング型貼付剤 |
WO2005115355A1 (ja) * | 2004-05-28 | 2005-12-08 | Hisamitsu Pharmaceutical Co., Inc. | 貼付製剤 |
-
2006
- 2006-12-25 BR BRPI0621655-2A patent/BRPI0621655A2/pt not_active IP Right Cessation
- 2006-12-25 KR KR1020087029711A patent/KR20090009951A/ko not_active Application Discontinuation
- 2006-12-25 ES ES06835183.2T patent/ES2466647T3/es active Active
- 2006-12-25 AU AU2006343077A patent/AU2006343077B2/en active Active
- 2006-12-25 JP JP2008514366A patent/JP5122445B2/ja active Active
- 2006-12-25 IN IN2543MUN2008 patent/IN266817B/en unknown
- 2006-12-25 CA CA2651596A patent/CA2651596C/en active Active
- 2006-12-25 MY MYPI20084469A patent/MY149152A/en unknown
- 2006-12-25 RU RU2008148131/15A patent/RU2428179C2/ru not_active IP Right Cessation
- 2006-12-25 WO PCT/JP2006/325813 patent/WO2007129427A1/ja active Application Filing
- 2006-12-25 CN CN200680054495XA patent/CN101460156B/zh active Active
- 2006-12-25 EP EP06835183.2A patent/EP2016939B1/en active Active
- 2006-12-25 NZ NZ572809A patent/NZ572809A/en not_active IP Right Cessation
-
2007
- 2007-05-07 US US11/797,722 patent/US7858114B2/en not_active Expired - Fee Related
-
2008
- 2008-10-31 NO NO20084614A patent/NO20084614L/no not_active Application Discontinuation
- 2008-11-09 IL IL195174A patent/IL195174A0/en unknown
-
2009
- 2009-09-04 HK HK09108096.7A patent/HK1130175A1/xx not_active IP Right Cessation
-
2010
- 2010-11-17 US US12/948,252 patent/US20110059141A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BRPI0621655A2 (pt) | 2011-12-20 |
US20070259028A1 (en) | 2007-11-08 |
RU2008148131A (ru) | 2010-06-20 |
US7858114B2 (en) | 2010-12-28 |
AU2006343077A1 (en) | 2007-11-15 |
MY149152A (en) | 2013-07-15 |
WO2007129427A1 (ja) | 2007-11-15 |
KR20090009951A (ko) | 2009-01-23 |
EP2016939A4 (en) | 2013-01-09 |
EP2016939B1 (en) | 2014-03-19 |
CA2651596C (en) | 2014-03-25 |
IN266817B (xx) | 2015-06-03 |
RU2428179C2 (ru) | 2011-09-10 |
NO20084614L (no) | 2009-02-06 |
AU2006343077B2 (en) | 2012-11-08 |
EP2016939A1 (en) | 2009-01-21 |
JPWO2007129427A1 (ja) | 2009-09-17 |
CN101460156B (zh) | 2011-06-08 |
JP5122445B2 (ja) | 2013-01-16 |
IL195174A0 (en) | 2009-08-03 |
CA2651596A1 (en) | 2007-11-15 |
NZ572809A (en) | 2011-02-25 |
CN101460156A (zh) | 2009-06-17 |
US20110059141A1 (en) | 2011-03-10 |
ES2466647T3 (es) | 2014-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1130175A1 (en) | Tansdermally absorbable preparation comprising anti-dementia agent | |
IL245513A0 (en) | Medical preparations containing ingenol-3-angelate | |
HK1207009A1 (en) | Absorbable hemostat | |
EP2016941A4 (en) | PREPARATION OF TRANSDERMALLY RESORBABLE DONEPZIL | |
HK1125295A1 (en) | Microtablet-based pharmaceutical preparation | |
EP2049713A4 (en) | TISSUE REJECTION | |
HK1146704A1 (en) | Transdermally absorbable preparation | |
EP1857103A4 (en) | TRANSDERMALLY ABSORBABLE PREPARATION | |
EP2027849A4 (en) | TOPICAL SKIN PREPARATION | |
GB2458228B (en) | External preparation for skin | |
IL198651A0 (en) | COMPOSITION COMPRISING (-)-Ôêå9-TRANS-TETRAHYDROCANNABIONOL | |
IL197235A0 (en) | Therapeutic compositions | |
EP1994933A4 (en) | AQUEOUS COMPOSITION | |
ZA200807486B (en) | Medicament formulations comprising fluoroquinolones | |
EP2062892A4 (en) | AGENT ENHANCING HYPERTENSION | |
GB0625783D0 (en) | Medicament | |
EP2030629A4 (en) | AGENT FOR IMPROVING LIPID METABOLISM | |
EP2124959A4 (en) | PHARMACEUTICAL COMPOSITION | |
GB0619375D0 (en) | Wound healing compositions | |
EP2060263A4 (en) | AGENT FOR IMPROVING LIPID METABOLISM | |
GB0705395D0 (en) | Breath deodoriser | |
GB0615064D0 (en) | Medicament | |
ZA200904476B (en) | Wound bed preparation | |
IL208396A0 (en) | Guided surgery | |
GB2442539B (en) | Cutlery forceps |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20141225 |